← Open Payments lookup

AMY GOTVASLEE: Open Payments

NPI 1396157830 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,298 in 81 payments from 21 companies in 2025. Trend: 2023 $960 · 2024 $923 · 2025 $1,298

Food & beverage: $1,298
CompanyPaymentsAmount
ABBVIE INC.16$204
Amgen Inc.12$153
Lilly USA, LLC10$133
Takeda Pharmaceuticals U.S.A., Inc.5$112
Novartis Pharmaceuticals Corporation6$109
Dexcom, Inc.5$105
Novo Nordisk Inc4$62
Astellas Pharma US Inc3$62
E.R. Squibb & Sons, L.L.C.3$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42

Products named: VRAYLAR, LEQVIO, Dexcom G6 Transmitter, MOUNJARO, OTEZLA, EVENITY, Veozah, CAMZYOS.

Industry payments across ND — which companies pay providers there.